RELATED: West Carrollton home to 'largest' spinal devices factory
“NuVasive delivered better than expected operating profitability and earnings per share results in the second quarter 2017, along with continued strength across our international business, growing at more than 20 percent for the third quarter in a row,” Greg Lucier, chairman and chief executive of NuVasive, said in a statement.
NuVasive reported second quarter 2017 total revenue of $260.6 million, a 10.3 percent increase compared to $236.2 million for the second quarter of 2016.
The company put net income at $12.7 million, or 22 cents per share, compared to $30.2 million, or 57 cents per share, for the second quarter of 2016.
On a non-general accounting practices basis, the company reported net income of $24.1 million, or 46 cents per share, compared to $20.6 million, or 40 cents a share, for the second quarter last year.
About the Author